Amgen Inc
Change company Symbol lookup
Select an option...
AMGN Amgen Inc
GSBD Goldman Sachs BDC Inc
LTRN Lantern Pharma Inc
JGGC Jaguar Global Growth Corporation I
WHG Westwood Holdings Group Inc
BNOX Bionomics Ltd
PSO Pearson PLC
ERNA Eterna Therapeutics Inc
INDP Indaptus Therapeutics Inc
TSLX Sixth Street Specialty Lending Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq), Evenity, LumaKras, Nplate, XGeva, and others. The Company focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.

Closing Price
$270.82
Day's Change
1.84 (0.68%)
Bid
--
Ask
--
B/A Size
--
Day's High
271.38
Day's Low
266.54
Volume
(Average)
Volume:
2,430,682

10-day average volume:
2,619,529
2,430,682

Upcoming Events

AMGN's fiscal year ends in December
There are no upcoming events for AMGN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
August 3, 2023Q2 2023 Earnings Release$5.00$3.92 to $4.84$4.65
April 27, 2023Q1 2023 Earnings Release$3.98$3.30 to $4.49$4.25
January 31, 2023Q4 2022 Earnings Release$4.09$3.94 to $4.25$4.36
November 3, 2022Q3 2022 Earnings Release$4.70$4.23 to $4.75$4.67

Past Dividends

Ex-dividend dateAmountRecord datePay date
August 17, 2023$2.13August 18, 2023September 8, 2023
May 17, 2023$2.13May 18, 2023June 8, 2023
February 14, 2023$2.13February 15, 2023March 8, 2023
November 16, 2022$1.94November 17, 2022December 8, 2022

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.